Fig. 1.
Fig. 1. Nucleotide sequence and predicted amino acid sequence ofTEL2. / Nucleotides are numbered beginning with +1 at the ATG start codon. Numbering of the aa sequence is italicized. A putative MAPK phosphorylation site (aa 10-13) is in bold type and italicized. Both the nucleotide and aa sequences of the PNT (aa 51-117) and ETS (aa 225-304) domains are in bold type and underlined. The last 10 aa of TEL2, used as a KLH-conjugated peptide for antibody production, are underlined. The stop codon used and additional in-frame stop codons in the 3′ UTR are italicized and marked with an asterisk. Within the 3′ UTR, an attta motif, associated with mRNA turnover, is in bold type and the putative polyadenylation signal, aataaa, is in bold type and underlined. This sequence has been assigned the GenBank accession number AF175387.

Nucleotide sequence and predicted amino acid sequence ofTEL2.

Nucleotides are numbered beginning with +1 at the ATG start codon. Numbering of the aa sequence is italicized. A putative MAPK phosphorylation site (aa 10-13) is in bold type and italicized. Both the nucleotide and aa sequences of the PNT (aa 51-117) and ETS (aa 225-304) domains are in bold type and underlined. The last 10 aa of TEL2, used as a KLH-conjugated peptide for antibody production, are underlined. The stop codon used and additional in-frame stop codons in the 3′ UTR are italicized and marked with an asterisk. Within the 3′ UTR, an attta motif, associated with mRNA turnover, is in bold type and the putative polyadenylation signal, aataaa, is in bold type and underlined. This sequence has been assigned the GenBank accession number AF175387.

Close Modal

or Create an Account

Close Modal
Close Modal